Research Output

Filter
Editorial
2020

A discussion on considerations in scientific integrity

Talmadge, J. E., Apr 2020, In : International Immunopharmacology. 81, 106332.

Research output: Contribution to journalEditorial

Fighting 2 Enemies: Cancer and COVID-19

Vose, J. M., May 13 2020, In : Oncology (Williston Park, N.Y.). 34, 5, 1 p.

Research output: Contribution to journalEditorial

Quantity does not equal quality: Scientific principles cannot be sacrificed

Rzymski, P., Nowicki, M., Mullin, G. E., Abraham, A., Rodríguez-Román, E., Petzold, M. B., Bendau, A., Sahu, K. K., Ather, A., Naviaux, A. F., Janne, P., Gourdin, M., Delanghe, J. R., Ochs, H. D., Talmadge, J. E., Garg, M., Hamblin, M. R. & Rezaei, N., Sep 2020, In : International Immunopharmacology. 86, 106711.

Research output: Contribution to journalEditorial

1 Scopus citations
2018

Predictive biomarkers for immune checkpoint inhibitor therapy: We need to keep searching

Huerter, M. M. & Ganti, A. K., Jul 1 2018, In : Journal of Thoracic Disease. 10, p. S2195-S2197

Research output: Contribution to journalEditorial

2 Scopus citations
2017

Bevacizumab in extensive-disease small cell lung cancer: The search continues

Kallam, A. & Ganti, A. K. P., May 1 2017, In : Translational Cancer Research. 6, p. S537-S538

Research output: Contribution to journalEditorial

1 Scopus citations

Delivery of personalized medicine with precision

Hayes, D. F. & Vose, J. M., 2017, In : JCO Precision Oncology. 2017, 1, p. 1-3 3 p.

Research output: Contribution to journalEditorial

Surgery for limited-stage small cell lung cancer: Ready for prime-time?

Ernani, V. & Ganti, A. K., Oct 1 2017, In : Journal of Thoracic Disease. 9, 10, p. 3576-3578 3 p.

Research output: Contribution to journalEditorial

2 Scopus citations

Which anti-CD20 antibody is better in follicular lymphoma?

Armitage, J. O. & Longo, D. L., Oct 5 2017, In : New England Journal of Medicine. 377, 14, p. 1389-1390 2 p.

Research output: Contribution to journalEditorial

5 Scopus citations
2016

Evolution

Cox, J. V. & Armitage, J. O., Jan 2016, In : Journal of oncology practice. 12, 1, p. 1-2 2 p.

Research output: Contribution to journalEditorial

Introduction: Natural product-based drug discovery in Immunopharmacology

Abe, F., Marceau, F. & Talmadge, J. E., Aug 1 2016, In : International Immunopharmacology. 37, p. 1-2 2 p.

Research output: Contribution to journalEditorial

3 Scopus citations

Relapsed small cell lung cancer: Is more better?

Ernani, V. & Ganti, A. K., 2016, In : Translational Cancer Research. 5, p. S1363-S1365

Research output: Contribution to journalEditorial

Resected small cell lung cancer-what do we do next?

Marr, A. S. & Ganti, A. K., Aug 2016, In : Annals of Translational Medicine. 4, 15, 288.

Research output: Contribution to journalEditorial

1 Scopus citations
2015

Controversies in the treatment of early-stage Hodgkin's lymphoma

Longo, D. L. & Armitage, J. O., Apr 23 2015, In : New England Journal of Medicine. 372, 17, p. 1667-1669 3 p.

Research output: Contribution to journalEditorial

12 Scopus citations

Genetic cancer susceptibility testing: Increased technology, increased complexity

Yu, P. P., Vose, J. M. & Hayes, D. F., Nov 1 2015, In : Journal of Clinical Oncology. 33, 31, p. 3533-3534 2 p.

Research output: Contribution to journalEditorial

8 Scopus citations

Rituximab maintenance therapy in diffuse large B-cell lymphoma: Is XY the most important variable?

Lunning, M. A. & Armitage, J. O., Jul 6 2015, In : Haematologica. 100, 7, p. 853-855 3 p.

Research output: Contribution to journalEditorial

2 Scopus citations

To Surveil or Not to Surveil

Armitage, J. O. & Vose, J. M., Dec 1 2015, In : Journal of Clinical Oncology. 33, 34, p. 3983-3984 2 p.

Research output: Contribution to journalEditorial

7 Scopus citations
2014

Grade II gliomas-not so low grade

Shonka, N. A., Dec 1 2014, In : Oncology (Williston Park, N.Y.). 28, 12, 1 p.

Research output: Contribution to journalEditorial

Improving breast cancer therapy with CDK4/6 inhibitors

Jaganathan, H., Overstreet, K. & Reed, E., Dec 1 2014, In : Clinical Breast Cancer. 14, 6, p. 379-380 2 p.

Research output: Contribution to journalEditorial

2 Scopus citations

Preface: Natural killer cells in cancer: Surveillance, progression, and therapy

Talmadge, J. E. & Whiteside, T. L., 2014, In : Critical Reviews in Oncogenesis. 19, 1-2, p. vii-viii

Research output: Contribution to journalEditorial

2013

Molecular advances come of age

Jacobs, P., Wood, L. & Armitage, J. O., Aug 2013, In : Transfusion and Apheresis Science. 49, 1, p. 6-8 3 p.

Research output: Contribution to journalEditorial

1 Scopus citations

Molecular advances come of age (Part II)

Jacobs, P., Wood, L. & Armitage, J. O., Oct 2013, In : Transfusion and Apheresis Science. 49, 2, p. 107-109 3 p.

Research output: Contribution to journalEditorial

2012

From the guest editor: Pressing questions in the care of patients with lymphomas

Armitage, J. O., Sep 2012, In : Cancer Journal (United States). 18, 5, p. 381-382 2 p.

Research output: Contribution to journalEditorial

Who benefits from surveillance imaging?

Armitage, J. O., Jul 20 2012, In : Journal of Clinical Oncology. 30, 21, p. 2579-2580 2 p.

Research output: Contribution to journalEditorial

17 Scopus citations
2011

25 years later: Endangered species or successful evolution?

Armitage, J. O., Davidson, N. E., Janjan, N. & Wood, W. C., 2011, In : ONCOLOGY. 25, 14, 3.

Research output: Contribution to journalEditorial

Conference on regulatory myeloid cells

Talmadge, J. E. & Gabrilovich, D. I., Jul 2011, In : International Immunopharmacology. 11, 7, 1 p.

Research output: Contribution to journalEditorial

International Immunopharmacology: Preface

Abe, F., Cao, X., Li, X. K. & Talmadge, J. E., Mar 2011, In : International Immunopharmacology. 11, 3, p. 293-294 2 p.

Research output: Contribution to journalEditorial

1 Scopus citations

Relapsed diffuse large B-cell lymphoma: Clinical utility of cell of origin

Vose, J. M., Nov 1 2011, In : Journal of Clinical Oncology. 29, 31, p. 4065-4066 2 p.

Research output: Contribution to journalEditorial

5 Scopus citations
2010

Proceedings of the 13th biennial South African Lymphoma Study Group Meeting - Cape Town October 2008

Armitage, J. O., Diehl, V., Engert, A., Jacobs, P. & Wood, L., Apr 2010, In : Transfusion and Apheresis Science. 42, 2, p. 125-128 4 p.

Research output: Contribution to journalEditorial

2009

Targeted therapy and hematological malignancy

Armitage, J. O., Jan 2009, In : Targeted Oncology. 4, 1, p. 1-2 2 p.

Research output: Contribution to journalEditorial

1 Scopus citations

Vascular medicine: A look forward

Holstein, S. A. & Hohl, R. J., Aug 2009, In : Clinical Pharmacology and Therapeutics. 86, 2, p. 117-119 3 p.

Research output: Contribution to journalEditorial

2008

Diffuse large B-cell lymphoma of the breast: A distinct entity?

Bierman, P. J., Villanueva, M. L. & Armitage, J. O., Feb 2008, In : Annals of Oncology. 19, 2, p. 201-202 2 p.

Research output: Contribution to journalEditorial

4 Scopus citations
2007

Editorial

Talmadge, J. & Taylor, P., Jan 2007, In : International Immunopharmacology. 7, 1, p. 1-2 2 p.

Research output: Contribution to journalEditorial

Proceedings of the 12th Biennial Congress - South African Lymphoma Study Group

Jacobs, P., Wood, L. & Armitage, J. O., Aug 2007, In : Transfusion and Apheresis Science. 37, 1, p. 27-29 3 p.

Research output: Contribution to journalEditorial

1 Scopus citations
2006

Advances in the treatment of hematologic malignancies. Part 1 of a 3-part series: Aggressive lymphomas

Fisher, R. I., Coiffier, B. & Vose, J. M., Apr 2006, In : Clinical Advances in Hematology and Oncology. 4, 4 SUPPL. 10, p. 1+3

Research output: Contribution to journalEditorial

Any drug that works has a target

Armitage, J. O., Oct 2006, In : Targeted Oncology. 1, 4, p. 179-180 2 p.

Research output: Contribution to journalEditorial

Associate Editor Dr. Fred L. Pearce to Retire from International Immunopharmacology

Hugli, T. E. & Talmadge, J. E., Nov 2006, In : International Immunopharmacology. 6, 11, 1 p.

Research output: Contribution to journalEditorial

Editorial

Talmadge, J. E., Hugli, T. E. & Fuminori, A., Aug 2006, In : International Immunopharmacology. 6, 8, 1 p.

Research output: Contribution to journalEditorial

1 Scopus citations

Editorial

Talmadge, J. E., Hugli, T. E. & Fuminori, A., Jul 2006, In : International Immunopharmacology. 6, 7, 1 p.

Research output: Contribution to journalEditorial

1 Scopus citations

Is there a place for routine imaging for patients in complete remission from aggressive lymphoma?

Armitage, J. O. & Loberiza, F. R., Jun 2006, In : Annals of Oncology. 17, 6, p. 883-884 2 p.

Research output: Contribution to journalEditorial

19 Scopus citations

Purine analogues in the treatment of lymphoid malignancies

Foss, F., Vose, J. M., Neumann, M. & Harris, M. E., Apr 2006, In : Seminars in hematology. 43, SUPPL. 2, p. S1

Research output: Contribution to journalEditorial

2005

Defining the stages of aggressive non-Hodgkin's lymphoma - A work in progress

Armitage, J. O., Mar 24 2005, In : New England Journal of Medicine. 352, 12, p. 1250-1252 3 p.

Research output: Contribution to journalEditorial

8 Scopus citations

Screening for dihydropyrimidine dehydrogenase deficiency

Grem, J. L., Jul 15 2005, In : Clinical Cancer Research. 11, 14, p. 5067-5068 2 p.

Research output: Contribution to journalEditorial

12 Scopus citations
2004

Adjuvant therapy for colon cancer: A historical perspective

Grem, J., Aug 4 2004, In : Journal of the National Cancer Institute. 96, 15, p. 1116-1117 2 p.

Research output: Contribution to journalEditorial

Open Access
3 Scopus citations

Mature results of adjuvant colon cancer trials from the Fluorouracil-only era

Grem, J. L., May 19 2004, In : Journal of the National Cancer Institute. 96, 10, p. 727-729 3 p.

Research output: Contribution to journalEditorial

Open Access
4 Scopus citations

Seminars in Oncology: Introduction

Armitage, J. O., Dec 2004, In : Seminars in Oncology. 31, SUPPL. 16, p. 1-2 2 p.

Research output: Contribution to journalEditorial

Towards understanding the peripheral T-cell lymphomas

Armitage, J. O., Vose, J. M. & Weisenburger, D. D., Oct 2004, In : Annals of Oncology. 15, 10, p. 1447-1449 3 p.

Research output: Contribution to journalEditorial

54 Scopus citations
2003

Radioimmunotherapy: A Novel Treatment Modality for B-Cell Non-Hodgkin's Lymphoma

Juweid, M., DeNardo, G. L., Graham, M. & Vose, J., 2003, In : Cancer Biotherapy and Radiopharmaceuticals. 18, 5, p. 673-674 2 p.

Research output: Contribution to journalEditorial

9 Scopus citations
2002

Combination therapy for non-Hodgkin’s lymphoma: An opportunity for pharmaceutical care in a specialty practice

Augustine, S. C., Norenberg, J. P., Colcher, D. M., Vose, J. M., Gobar, L. S., Dukat, V. J., Hohenstein, M. A., Rutar, F. J., Jacobson, D. A. & Tempero, M. A., 2002, In : Journal of the American Pharmaceutical Association (Washington, D.C. : 1996). 42, 1, p. 93-100 8 p.

Research output: Contribution to journalEditorial

2 Scopus citations

Editorial

Armitage, J. O., 2002, In : Clinical lymphoma. 2, 4, p. 200-201 2 p.

Research output: Contribution to journalEditorial